Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Homer1em1flox/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Homer1em1flox/Cya

Common Name
Homer1-flox
Product ID
S-CKO-09617
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-26556-Homer1-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Homer1-flox Mouse (Catalog S-CKO-09617) were purchased from Cyagen.”
cKO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
cKO Models
Basic Information
Strain Name
Homer1-flox
Strain ID
CKOCMP-26556-Homer1-B6J-VA
Gene Name
Homer1
Product ID
S-CKO-09617
Gene Alias
SYN47, Ves-1, vesl-1, homer-1, PSD-Zip45
Background
C57BL/6JCya
Gene Full Name
homer scaffolding protein 1
Modification
Conditional knockout
NCBI ID
26556 (Mouse)
Phenotype
MGI:1347345
Chromosome
Chr 13 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000079086
NCBI Transcript ID
NM_152134
Target Region
Exon 2
Size of Effective Region
~0.7 kb
Overview of Gene Research
Homer1, a synaptic scaffold protein, is crucial for regulating glutamatergic synapses and spine morphogenesis [4]. It interacts with various proteins like metabotropic glutamate receptors (mGluRs), modulating calcium signaling, long-term potentiation, and dendritic spine growth. It also plays a part in integrating different signal transduction pathways within the postsynaptic density, being involved in motor and cognitive functions [2].

In disease-related studies, Homer1 has shown significant impacts. In intracerebral hemorrhage (ICH) models, overexpression of Homer1 promotes the conversion of A1 astrocytes (associated with neuroinflammation) to A2 astrocytes (neuroprotective), inhibits MAPK signaling activation, and improves outcomes, associated with changes in inflammatory and anti-inflammatory factors [1]. In middle cerebral artery occlusion-induced retinal ischemia models, Homer1 overexpression protects retinal ganglion cells from pyroptosis by inhibiting endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation [3]. In ischemic stroke models, knockdown of Homer1 promotes neuronal death by enhancing necroptotic signaling and inflammation, while injection of Homer1 protein reduces injury and improves outcomes [5]. In chronic social stress models, disruption of Homer1/mGluR5 coupling is observed, and Homer1 knockout mice show hyperactivity and hypothalamic-pituitary-adrenal axis dysregulation [6].

In conclusion, Homer1 is essential for synaptic function and spine stability. Through gene knockout (KO) and other genetic models, its role in various disease conditions such as ICH, retinal ischemia, ischemic stroke, and stress-induced psychiatric disorders has been revealed. These models have provided insights into potential therapeutic targets related to Homer1 in treating these diseases.

References:
1. Fei, Xiaowei, Dou, Ya-Nan, Wang, Li, Wei, Jialiang, Fei, Zhou. 2022. Homer1 promotes the conversion of A1 astrocytes to A2 astrocytes and improves the recovery of transgenic mice after intracerebral hemorrhage. In Journal of neuroinflammation, 19, 67. doi:10.1186/s12974-022-02428-8. https://pubmed.ncbi.nlm.nih.gov/35287697/
2. de Bartolomeis, Andrea, Barone, Annarita, Buonaguro, Elisabetta Filomena, Vellucci, Licia, Iasevoli, Felice. 2022. The Homer1 family of proteins at the crossroad of dopamine-glutamate signaling: An emerging molecular "Lego" in the pathophysiology of psychiatric disorders. A systematic review and translational insight. In Neuroscience and biobehavioral reviews, 136, 104596. doi:10.1016/j.neubiorev.2022.104596. https://pubmed.ncbi.nlm.nih.gov/35248676/
3. Lv, Weihao, Wu, Xiuquan, Dou, Yanan, Fei, Zhou, Fei, Fei. 2023. Homer1 Protects against Retinal Ganglion Cell Pyroptosis by Inhibiting Endoplasmic Reticulum Stress-Associated TXNIP/NLRP3 Inflammasome Activation after Middle Cerebral Artery Occlusion-Induced Retinal Ischemia. In International journal of molecular sciences, 24, . doi:10.3390/ijms242316811. https://pubmed.ncbi.nlm.nih.gov/38069134/
4. Yoon, Sehyoun, Piguel, Nicolas H, Khalatyan, Natalia, Savas, Jeffrey N, Penzes, Peter. 2021. Homer1 promotes dendritic spine growth through ankyrin-G and its loss reshapes the synaptic proteome. In Molecular psychiatry, 26, 1775-1789. doi:10.1038/s41380-020-00991-1. https://pubmed.ncbi.nlm.nih.gov/33398084/
5. Lv, Weihao, Zhang, Qianqian, Li, Yuanming, Zhang, Lei, Fei, Zhou. 2023. Homer1 ameliorates ischemic stroke by inhibiting necroptosis-induced neuronal damage and neuroinflammation. In Inflammation research : official journal of the European Histamine Research Society ... [et al.], 73, 131-144. doi:10.1007/s00011-023-01824-x. https://pubmed.ncbi.nlm.nih.gov/38091015/
6. Wagner, Klaus V, Hartmann, Jakob, Labermaier, Christiana, Müller, Marianne B, Schmidt, Mathias V. 2015. Homer1/mGluR5 activity moderates vulnerability to chronic social stress. In Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40, 1222-33. doi:10.1038/npp.2014.308. https://pubmed.ncbi.nlm.nih.gov/25409593/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Publications
ADVANCED SCIENCE
2024-12-11
Single-Nucleus RNA Sequencing Reveals That Gabra6+ Neurons in Prefrontal Cortex Promote the Progression of PTSD After Shockwave-Induced TBI
Read More
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research